HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the sixteen brokerages that are covering the company, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average 1-year price target among analysts that have covered the stock in the last year is $316.59.
A number of equities analysts have recently weighed in on HCA shares. TD Cowen cut their target price on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a research note on Tuesday, April 30th. Raymond James lifted their price objective on HCA Healthcare from $300.00 to $330.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Oppenheimer lifted their target price on shares of HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a research note on Monday, April 29th. Wells Fargo & Company raised their price objective on shares of HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a report on Thursday, March 28th. Finally, Barclays increased their target price on HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a research report on Monday, April 29th.
View Our Latest Analysis on HCA
Insiders Place Their Bets
Hedge Funds Weigh In On HCA Healthcare
Hedge funds and other institutional investors have recently bought and sold shares of the company. Oak Thistle LLC purchased a new stake in shares of HCA Healthcare during the third quarter worth approximately $206,000. U.S. Capital Wealth Advisors LLC grew its stake in shares of HCA Healthcare by 3.2% during the third quarter. U.S. Capital Wealth Advisors LLC now owns 2,801 shares of the company’s stock worth $689,000 after purchasing an additional 88 shares in the last quarter. Valeo Financial Advisors LLC raised its stake in HCA Healthcare by 5.8% in the third quarter. Valeo Financial Advisors LLC now owns 1,267 shares of the company’s stock valued at $312,000 after buying an additional 69 shares in the last quarter. Commonwealth Equity Services LLC raised its position in shares of HCA Healthcare by 0.6% during the 3rd quarter. Commonwealth Equity Services LLC now owns 24,758 shares of the company’s stock worth $6,090,000 after acquiring an additional 151 shares in the last quarter. Finally, Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its holdings in shares of HCA Healthcare by 1.9% in the 3rd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 37,728 shares of the company’s stock valued at $9,280,000 after buying an additional 700 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
HCA Healthcare Stock Up 0.7 %
Shares of HCA opened at $310.06 on Tuesday. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. The stock has a market capitalization of $81.21 billion, a price-to-earnings ratio of 15.46, a PEG ratio of 1.44 and a beta of 1.66. HCA Healthcare has a 52 week low of $215.96 and a 52 week high of $335.83. The stock has a fifty day moving average of $321.84 and a 200-day moving average of $298.27.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. During the same period in the prior year, the business posted $4.93 earnings per share. HCA Healthcare’s quarterly revenue was up 11.2% on a year-over-year basis. As a group, sell-side analysts anticipate that HCA Healthcare will post 20.74 earnings per share for the current fiscal year.
HCA Healthcare declared that its board has authorized a share repurchase program on Tuesday, January 30th that allows the company to repurchase $6.00 billion in shares. This repurchase authorization allows the company to reacquire up to 7.4% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s management believes its stock is undervalued.
HCA Healthcare Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date of this dividend is Friday, June 14th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More
- Five stocks we like better than HCA Healthcare
- What is a Dividend King?
- Tech Earnings Insights: Where Opportunity Meets Uncertainty
- What is the Shanghai Stock Exchange Composite Index?
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Following Congress Stock Trades
- 3 Value Stocks You Can Buy Before They Become Big
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.